Cargando…

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease

BACKGROUND: Sensitive cognitive global scores are beneficial in screening and monitoring for prodromal Alzheimer's disease (AD). Early cortical changes provide a novel opportunity for validating established cognitive total scores against the biological disease markers. METHODS: We examined how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paajanen, T., Hänninen, T., Aitken, A., Hallikainen, M., Westman, E., Wahlund, L.-O., Sobow, T., Mecocci, P., Tsolaki, M., Vellas, B., Muehlboeck, S., Spenger, C., Lovestone, S., Simmons, A., Soininen, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919432/ https://www.ncbi.nlm.nih.gov/pubmed/24516412 http://dx.doi.org/10.1159/000356725

Ejemplares similares

Education increases reserve against Alzheimer’s disease—evidence from structural MRI analysis
por: Liu, Yawu, et al.
Publicado: (2012)

Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease
por: Westman, Eric, et al.
Publicado: (2011)

Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts
por: Khan, Wasim, et al.
Publicado: (2014)

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
por: Aguilar, Carlos, et al.
Publicado: (2014)

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer’s Disease
por: Boccardi, Virginia, et al.
Publicado: (2019)

The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration
por: Haanpää, Ramona M., et al.
Publicado: (2015)

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease
por: Pereira, Joana B., et al.
Publicado: (2016)

The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study
por: Hallikainen, Ilona, et al.
Publicado: (2014)

The Effect of Age Correction on Multivariate Classification in Alzheimer’s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects
por: Falahati, Farshad, et al.
Publicado: (2015)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation
por: Greco, Ines, et al.
Publicado: (2012)

Prospective CERAD Neuropsychological Assessment in Patients With Multiple System Atrophy
por: Maass, Fabian, et al.
Publicado: (2022)

Stability of graph theoretical measures in structural brain networks in Alzheimer’s disease
por: Mårtensson, Gustav, et al.
Publicado: (2018)

Plasma proteins predict conversion to dementia from prodromal disease
por: Hye, Abdul, et al.
Publicado: (2014)

Predicting Progression of Alzheimer’s Disease Using Ordinal Regression
por: Doyle, Orla M., et al.
Publicado: (2014)

Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
por: Leung, Rufina, et al.
Publicado: (2013)

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness()
por: Lebedev, A.V., et al.
Publicado: (2014)

The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis
por: Schmid, Nicole S., et al.
Publicado: (2014)

Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden
por: Kiddle, Steven John, et al.
Publicado: (2012)

Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid
por: Falahati, Farshad, et al.
Publicado: (2017)

A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis
por: Voyle, Nicola, et al.
Publicado: (2015)

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study
por: Hallikainen, Ilona, et al.
Publicado: (2012)

Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer’s disease from healthy individuals
por: Müller, Stephan, et al.
Publicado: (2019)

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease
por: Khan, Wasim, et al.
Publicado: (2017)

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective
por: Watermeyer, Tamlyn, et al.
Publicado: (2019)

Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
por: Seppälä, T T, et al.
Publicado: (2010)

In vivo (1)H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment
por: Westman, Eric, et al.
Publicado: (2009)

TheHiveDB image data management and analysis framework
por: Muehlboeck, J-Sebastian, et al.
Publicado: (2014)

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer’s Disease
por: Kreuzer, Annika, et al.
Publicado: (2021)

Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance
por: Zhang, TianHong, et al.
Publicado: (2015)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
por: Proitsi, P, et al.
Publicado: (2015)

Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
por: Kiddle, S J, et al.
Publicado: (2015)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
por: Benejam, Bessy, et al.
Publicado: (2020)

AVRA: Automatic visual ratings of atrophy from MRI images using recurrent convolutional neural networks
por: Mårtensson, Gustav, et al.
Publicado: (2019)

Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts
por: Wallert, John, et al.
Publicado: (2021)

Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment
por: Westman, Eric, et al.
Publicado: (2012)

Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment Battery (CERAD-NAB)
por: Mistridis, Panagiota, et al.
Publicado: (2015)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
por: Kim, Min, et al.
Publicado: (2017)

Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
por: Proitsi, Petroula, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t6tf3ijhdfhl523r7ls8rge0vu